Science1 publisher3 min readPublished
Sixteen molecules that shift during menopause track with Alzheimer's risk in older women
Toronto and UCSF researchers report that older women with higher levels of 16 menopause-linked molecules were 15 percent likelier to develop Alzheimer's. The authors see menopause as a window for early-warning testing, though the evidence so far is a correlation.
The Scientist · Science desk
Drafted by a language model from the sources cited here and checked against its claim ledger before publication. How we use AISend a correction

What happened
- The midlife study enrolled 80 healthy women aged 43 to 58 at different stages of the menopausal transition, plus a smaller comparison group of men of similar age.
- One group of Alzheimer's-linked molecules rose with follicle-stimulating hormone, and a second, inflammation-linked group rose as estradiol fell.
- Women who reported night sweats showed a greater increase in the inflammatory molecules.
- In a late-life analysis of almost 12,000 women in their sixties and early seventies, higher levels of the 16 molecules also went with worse memory.
Compiled by The ScientistSomething wrong?How this is made
Why it matters
- capability If the 16 molecules hold up, a test taken during the menopausal transition could pick out women for early-intervention therapy years before Alzheimer's symptoms appear.
- constraint Showing that a woman's own rise at menopause predicts her later diagnosis will take a cohort measured in midlife and followed into old age, a study that runs for decades.
- decision A 15 percent relative gap is small for sorting individuals, so for now the panel suits choosing participants for prevention trials better than advising single patients.
The most useful comparison in the Nature Medicine paper [18] is hormones against age. In midlife, age and hormone levels move together, but only loosely. The team reports that the molecular changes followed hormone levels more closely than biological age [7]. That result is the main evidence that the shift comes from menopause and not just from getting older. "It was really important to us that we be more precise and capture these years of hormonal flux," said Madeline Wood Alexander, the first author and a graduate student at the University of Toronto [5][19].
Sixteen of more than 100 brain-health molecules changed during the transition [12]. That is under 16 percent of the panel [21]. When a group this size is screened for that many candidates, some hits will be chance. In my view the 16 need to show up again in a second midlife group before anyone designs a test around them.
The Alzheimer's link comes from a separate step. The late-life figures were collected from four previous papers [10], so the women in their sixties and seventies are different people from the women measured in midlife [22]. The thing this doesn't tell you is whether a woman whose levels climbed at 50 is the one diagnosed at 70. Symptom history is the closest the study gets to a link across the decades. Older women who reported hot flashes during menopause still had higher levels of the inflammatory molecules [11].
The 15 percent figure is relative [13]. Discover's account does not give the baseline rate of Alzheimer's in the older women, so the absolute difference in risk is unknown. The relationship is correlational, and the researchers cannot yet say whether one directly affects the other [23].
Kaitlin Casaletto is a co-senior author and an associate professor at UCSF's Fein Memory and Aging Center [20]. She explained that the finding is not that menopause causes dementia directly. It is that measuring certain molecules during menopause may make it possible to predict Alzheimer's risk [14]. "Midlife is a critical window for both men and women where we can really set up the brain to be more resilient or more vulnerable to dementia in later life," Casaletto said [15].
The timing makes sense. Alzheimer's mostly affects adults 65 and older, but the biological changes behind it begin years, possibly decades, before symptoms [2]. According to the National Institute on Aging, the average age of menopause in the U.S. is 52, after a transition of about two to eight years [3]. Earlier work, including a study in The Lancet, linked early-onset menopause to higher dementia risk [16]. Women are around twice as likely as men to develop Alzheimer's, a gap thought to come at least partly from longer lives [1]. "We don't want it to be viewed as a bad thing, but as an opportunity to better understand and maybe modify the biology of brain aging in women," Wood Alexander said [17].
What to watch
- Whether the 16-molecule shift replicates in a second, larger midlife cohort beyond the original 80 women.
- A prospective study that measures the panel during menopause and follows the same women through to diagnosis.
- Absolute Alzheimer's rates by molecule level in the 12,000-woman analysis, needed to judge the panel as a screening test.